Eric Topol, MDs Post Two new studies zero in on the anti-inflammatory effects of the GLP-1 family of drugs, independent of weight loss, highlighting the gut-brain axis (modulating TLR response) and the gut GIP impact by Daniel Drucker and colleagues This opens up the possibility of using GLP-1 drugs in the treatment of long COVID or in conditions like schizophrenia that use the TLR pathway to activate neuroinflammation
That said, you can and should use more creative means to boost glutathione production as low levels of this crucial compound dramatically increase your risk of disease and vulnerability to toxins
Athletes, biohackers, and integrative health patients support this option for improved resilience
What clinical evidence supports compounded GLP-1 medications over branded options
They can assess whether dose adjustment, timing changes, or alternative strategies better fit your clinical needs and genetic predispositions
Plus, AID systems give you a few more tools to put into action to balance glucose levels
